Reckitt Benckiser Group plc (LON:RKT – Get Free Report) has received an average rating of “Hold” from the seven research firms that are presently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is GBX 6,204.29.
Several research analysts have weighed in on RKT shares. Citigroup lowered their price target on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Berenberg Bank cut their price objective on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating for the company in a report on Friday, April 24th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Reckitt Benckiser Group from GBX 5,460 to GBX 5,430 and set a “hold” rating on the stock in a report on Tuesday, April 28th. Jefferies Financial Group reaffirmed a “hold” rating and set a GBX 5,600 price target on shares of Reckitt Benckiser Group in a research report on Tuesday, June 16th. Finally, Royal Bank Of Canada reissued a “neutral” rating and issued a GBX 6,200 price objective on shares of Reckitt Benckiser Group in a research report on Friday, May 15th.
View Our Latest Stock Analysis on Reckitt Benckiser Group
Insiders Place Their Bets
Reckitt Benckiser Group Stock Performance
Shares of LON RKT opened at GBX 5,008 on Thursday. The stock has a 50 day moving average price of GBX 4,701.80 and a 200 day moving average price of GBX 5,386.17. Reckitt Benckiser Group has a 52 week low of GBX 3,866 and a 52 week high of GBX 6,522.92. The company has a debt-to-equity ratio of 108.83, a quick ratio of 0.46 and a current ratio of 0.85. The stock has a market capitalization of £31.80 billion, a PE ratio of 10.29, a price-to-earnings-growth ratio of 1.10 and a beta of 0.25.
Reckitt Benckiser Group Company Profile
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Featured Articles
- Five stocks we like better than Reckitt Benckiser Group
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
